Dowling & Yahnke LLC Abb Vie Inc. Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 78,132 shares of ABBV stock, worth $13.4 Million. This represents 4.88% of its overall portfolio holdings.

Number of Shares

78,132

Previous 78,677 0.69%

Holding current value

$13.4 Million

Previous $12.1 Million 12.98%

% of portfolio

4.88%

Previous 0.57%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $73,144 - $83,891	-545 Reduced 0.69%	78,132 $10.5 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $26,835 - $34,117	-195 Reduced 0.25%	78,677 $12.1 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $76,020 - $94,320	-576 Reduced 0.73%	78,872 $12.8 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $53,822 - $68,100	-501 Reduced 0.63%	79,448 $10.8 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $87,567 - $99,401	823 Added 1.04%	79,949 $8.62 Million

Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $106,472 - $118,616	1,012 Added 1.3%	79,126 $8.91 Million
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $10,434 - $11,487	-102 Reduced 0.13%	78,114 $8.45 Million
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $120,413 - $162,570	1,496 Added 1.95%	78,216 $8.38 Million
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $25,343 - $29,744	-295 Reduced 0.38%	76,720 $6.72 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $428,407 - $573,273	5,839 Added 8.2%	77,015 $7.56 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $70,111 - $106,297	-1,087 Reduced 1.5%	71,176 $5.42 Million
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $33,973 - $42,507	471 Added 0.66%	72,263 $6.4 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $16,500 - $19,838	-262 Reduced 0.36%	71,792 $5.44 Million
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $62,152 - $79,445	-946 Reduced 1.3%	72,054 $5.24 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $179,581 - $211,359	2,328 Added 3.29%	73,000 $5.88 Million
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $23,121 - $28,514	297 Added 0.42%	70,672 $6.66 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $79,485 - $88,362	-894 Reduced 1.25%	70,375 $6.66 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $50,366 - $59,595	-561 Reduced 0.78%	71,269 $6.6 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $352,122 - $471,524	-3,827 Reduced 5.06%	71,830 $6.8 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $6.8 Million - $7.45 Million	-75,896 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $5.3 Million - $6.77 Million	75,896	75,896 $6.74 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Abb Vie Inc. Transaction History